Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 293.30
+20.60 (7.55%)
At close: Sep 4, 2026
Trident Lifeline Market Cap
Trident Lifeline has a market cap or net worth of 3.5 billion as of September 4, 2026. Its market cap has increased by 1.64% in one year.
Market Cap
3.50B
Enterprise Value
4.26B
Revenue
1.39B
Ranking
n/a
PE Ratio
16.38
Stock Price
293.30
ChartMarket Cap Chart
Since October 10, 2022, Trident Lifeline's market cap has increased from 1.24B to 3.50B, an increase of 181.43%. That is a compound annual growth rate of 30.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 3.50B | -5.60% |
| Dec 31, 2025 | 3.71B | 15.15% |
| Dec 30, 2024 | 3.22B | 48.94% |
| Dec 29, 2023 | 2.16B | 51.61% |
| Dec 30, 2022 | 1.43B | 14.66% |
| Oct 10, 2022 | 1.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Albert David | 4.90B |
| Jenburkt Pharmaceuticals | 4.57B |
| Medicamen Biotech | 3.44B |
| Ambalal Sarabhai Enterprises | 3.35B |
| Medico Remedies | 3.30B |
| BDH Industries | 2.98B |
| Gennex Laboratories | 2.94B |
| Astonea Labs | 2.82B |